He spent years building technology. Then he found a reason to build technology that could help save lives. Dinos Matheou shares how a journey through engineering, software and international innovation led him to entrepreneurship—and to using AI to rethink the future of heart care.

Dinos Matheou is the founder and Managing Director of MEDTL Medical Technologies Ltd., a Cyprus-based medical technology company developing artificial intelligence solutions for cardiology. With a background in telecommunications, software engineering, and large-scale technology systems, he has contributed to international high-innovation projects, including Sirius satellite radio in the United States, combining engineering thinking with business strategy.

At MEDTL, he leads the development of the AI-Heart platform, an advanced ECG analysis system that leverages Artificial Intelligence algorithms for early detection of cardiac diseases and enhanced clinical decision-making. His vision focuses on creating a new model of preventive medicine, where artificial intelligence acts as a tool to empower phycisians , enabling faster, more accurate, and more accessible care worldwide.

He combines technological innovation, entrepreneurial leadership, and a deep understanding of clinical needs, aiming to shape the next generation of digital cardiology and drive global adoption of innovative healthcare solutions.